Clin2
NCT05941234Possibly a fitRecruiting

Studying stem cells and blood patterns in glioblastoma

Glioblastoma, IDH-wildtype

Part of Cancer clinical trials.

This study analyzes tissue and health-related biological data from people with glioblastoma to learn what’s happening in the tumor. The results may help improve future ways to understand and treat glioblastoma using advanced computer analysis.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a brain tumor diagnosis called glioblastoma in the upper part of the brain (supratentorial).
  • Your case is either first diagnosis or a documented first recurrence after earlier glioblastoma surgery.
  • Your doctors believe neurosurgery is a suitable option for you at this center.
  • You are age 18 or older.
  • You can sign a consent form saying you agree to join the study.
  • The surgery tissue sample must be enough for routine testing and for this research.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06319027Recruiting· Phase 2
Can brain scans help predict glioblastoma progression?

This trial is testing whether certain details on brain scans can help doctors better predict how brain cancer (glioblastoma) will progress. You may be eligible if you are newly diagnosed with this type of cancer and plan to receive standard treatment.

Birmingham, Alabama
NCT06620055Recruiting
Artificial intelligence for better glioma treatment

This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.

Aviano, Pordenone
NCT03526822Recruiting
Study of new glioblastoma using MRI scans and lab markers

This study follows people newly diagnosed with glioblastoma to see how certain lab signals (MMP2 and MMP9) match up with MRI scan features. It may help doctors better understand the disease and how it appears on imaging, but it’s mainly observational.

Marseille
NCT06113705Recruiting
Better MRI and blood tests for glioblastoma treatment response

This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.

Rozzano
NCT06575452Recruiting
Using RNA modifications to diagnose and treat gliomas

This trial studies whether changes in RNA (the instructions inside cells) can help doctors better diagnose and treat gliomas, a type of brain tumor. If you are scheduled for surgery to remove a suspected glioma and have not had prior treatment, you may be able to join.

Montpellier, Hérault
NCT07731555Recruiting
Studying the brain barrier in glioblastoma

This study looks at how the brain's protective barrier works in people with glioblastoma. Researchers will study tumor tissue and use special scans to learn more, which might help improve future treatments.

Beaumont

Hear when a new Glioblastoma, IDH-wildtype trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.